Olema Pharmaceuticals, Inc.OLMANASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
5Y CAGR+76.2%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
+76.2%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
17x
Strong expansion
Streak
1 yr
Consecutive growthStrong
PeriodValueYoY Change
TTM$187000.00-
2024$0.00-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$11000.00+21.8%
2019$9033.00+9.6%
2018$8244.00-